1. Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
   Maria Krchniakova et al, 2022, Frontiers in Pharmacology CrossRef